PTGS2 and neoplasm: SDA inhibits the action of cyclooxogenase-2 (COX-2) and arachidonate 5-lypoxigenase (ALOX5), reducing prostaglandins (e.g., PGE2) and leukotrienes that enhance tumor growth [42,43].